GlaxoSmithKline (GSK) has told us it is having problems with the supply of Lamictal. This is due to manufacturing problems.
A mother and son who both have epilepsy have started a petition to persuade the UK government to re-invest a recent pharmaceutical company fine into epilepsy healthcare services.
Pfizer and Flynn Pharma were fined £84.2m and £5.2m respectively for over-charging the NHS for life-saving epilepsy medicine phenytoin sodium.
Pharmaceuticals company Pfizer, which manufactures the epilepsy medicine phenytoin sodium capsules, has been fined a record £84.2 million by the Competition and Markets Authority (CMA). The company has been found to be breaking competition law by charging what the CMA said were 'excessive and unfair' prices in the UK for the medicine.